November 14, 2016 — HealthMyne will be unveiling and providing demonstrations of their new Quantitative Imaging Decision Support (QIDS) commercial platform at the 2016 annual meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 1 in Chicago.
The QIDS software platform combines imaging data with electronic medical record, radiation therapy and other clinical systems information to provide clinical decision support in the primary read. Currently focused on radiology and oncology, with future expansion into other specialties, QIDS (pronounced ‘quids’) is designed to positively impact clinical productivity and prepares radiologists for the transition to value-based payment.
HealthMyne asserts that in order for radiologists to extend their value as a member of the care team, highly curated evidence-based narratives, imaging analytics and patient cohort analysis must be generated to provide clinical decision support in the primary read, thereby enabling improved cancer diagnosis, staging and treatment.
Attendees of RSNA who take part in a demonstration of the QIDS platform can simultaneously make a difference for children and adults living with cancer. For each demo given, HealthMyne will make a $25 donation to Gilda’s Club of Madison.
For more information: www.healthmyne.com